ArticleBMC medical imaging2024
MRI-based radiomic and machine learning for prediction of lymphovascular invasion status in breast cancer.
Article in BMC medical imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Q RadFusion: Hybrid Quantum Classical Radiogenomic Framework for Breast Cancer Diagnosis.Research square · 2025Article
- Prediction of lymphovascular invasion in invasive breast cancer via intratumoral and peritumoral multiparametric magnetic resonance imaging machine learning-based radiomics with Shapley additive explanations interpretability analysis.Quantitative imaging in medicine and surgery · 2025Article
- Establishment of a predictive nomogram for breast cancer lympho-vascular invasion based on radiomics obtained from digital breast tomography and clinical imaging features.BMC medical imaging · 2025Article
- Decoding Intratumoral Heterogeneity in Breast Cancer: The Evolution From Radiomics to Topological Quantification for Predicting Lymphovascular Invasion.Cancer control : journal of the Moffitt Cancer CenterReview
- Transformer-Based Deep Learning Model Using MRI-Derived Microvascular Atlas for Predicting Lymphovascular Invasion in Breast Cancer Patients.Technology in cancer research & treatmentArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveLymphovascular invasion (LVI) is critical for the effective treatment and prognosis of breast cancer (BC). This study aimed to investigate the value of eight machine learning models based on MRI radiomic features for the preoperative prediction of LVI status in BC.
methodsA total of 454 patients with BC with known LVI status who underwent breast MRI were enrolled and randomly assigned to the training and validation sets at a ratio of 7:3. Radiomic features were extracted from T2WI and dynamic contrast-enhanced (DCE) of MRI sequences, the optimal feature filter and LASSO algorithm were used to obtain the optimal features, and eight machine learning algorithms, including LASSO, logistic regression, random forest, k-nearest neighbor (KNN), support vector machine, gradient boosting decision tree, extreme gradient boosting, and light gradient boosting machine, were used to construct models for predicating LVI status in BC. The area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, and specificity were used to evaluate the performance of the models.
resultsEighteen radiomic features were retained to construct the radiomic signature. Among the eight machine learning algorithms, the KNN model demonstrated superior performance to the other models in assessing the LVI status of patients with BC, with an accuracy of 0.696 and 0.642 in training and validation sets, respectively.
conclusionThe eight machine learning models based on MRI radiomics serve as reliable indicators for identifying LVI status, and the KNN model demonstrated superior performance.This model offers substantial clinical utility, facilitating timely intervention in invasive BC and ultimately aiming to enhance patient survival rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.